Novartis’s Cancer Treatment Pluvicto Shows Positive Results in Trial

Novartis’s Cancer Treatment Pluvicto Shows Positive Results in Trial · The Wall Street Journal

In This Article:

Pluvicto demonstrated positive results in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.